Zeal Access Editorial: Why is Canada 13th?

This week, Health Canada and the Patented Medicine Prices Review Board (PMPRB) hosted a webinar outlining their proposed changes to the Patented Medicines Regulations. Under the new proposals, the pricing of drugs will be compared to their prices in 12 other countries so that Canadians will pay a price for the drug that is comparable to other countries.

Read More